Toronto, Canada

Sachdev S Sidhu

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 4 CIPO patents. Top assignee: Antlera Therapeutics Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sachdev S Sidhu. Retrieved from https://idiyas.com/inventor/sachdev-s-sidhu-d6h34v1t

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.5

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sachdev S Sidhu: Innovator in Cancer Research

Introduction

Sachdev S Sidhu is a prominent inventor based in Toronto, Canada. He has made significant contributions to the field of cancer research, particularly in developing methods to combat pancreatic cancer. With a total of 2 patents to his name, Sidhu is recognized for his innovative approaches to medical challenges.

Latest Patents

Among his latest patents, Sidhu has developed a method for screening compounds that inhibit the proliferation of pancreatic cancer cells with a loss-of-function mutation in the RNF43 gene. Additionally, he holds a patent for antibodies that bind to LRP6 proteins and methods of use, showcasing his commitment to advancing cancer treatment.

Career Highlights

Sidhu is currently associated with Antlera Therapeutics Inc., where he continues to push the boundaries of cancer research. His work is instrumental in developing therapies that could potentially save lives and improve patient outcomes.

Collaborations

He collaborates with notable colleagues such as Jason Moffat and Guohua Pan, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Sachdev S Sidhu's contributions to cancer research through his patents and collaborations highlight his role as an innovator in the medical field. His work continues to inspire advancements in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…